Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.
about
Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- StimulationImmunity to rotavirus infection in mice.Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic miceReactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependentAbsence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.The human cytomegalovirus UL26 protein antagonizes NF-κB activation.Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon.Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.Antiviral T cell response triggers cytomegalovirus hepatitis in mice.Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes.CD4 T cell responses in latent and chronic viral infections.Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines.Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infectionTissue-specific control of latent CMV reactivation by regulatory T cells.Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes.Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection.Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus.The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitisMurine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.Tumor Necrosis Factor Alpha-Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in Murine Cytomegalovirus-Infected Newborn Mice.BK virus infection activates the TNFα/TNF receptor system in Polyomavirus-associated nephropathy.Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection.Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus.Regulation of transgene expression in genetic immunization.
P2860
Q27481475-4AEFFEB7-ADC5-4252-938E-C20E77798F1DQ33547156-63817972-5A34-4283-8D8A-25222E2DF720Q33782971-C83AC644-0E13-4E82-89BB-E221A373C5F3Q33852869-EA5D01A0-27CF-43DB-AEFE-F1AEC3ACC0BAQ34013634-FB54820E-80F6-4897-A5E8-F2C0C90F9165Q34465970-A3990112-D9BD-4AB9-86F5-C3C3BF8B45DCQ34594875-D34D4A31-271F-4D1B-AE01-2DE5DC2885B4Q35871524-596FAFEF-CFFA-4C5E-BB30-0CF72663EFEFQ35874845-00843D79-F109-4EEE-8792-E69000CD23D4Q35875143-A8803E51-AA1C-42D5-888C-E517B38D33A4Q36363051-5F68943F-0A51-41ED-A67B-523ABCFAAB35Q36365733-A5080F78-C7C3-4810-9284-3955F30931CDQ36380797-C417AF25-8AB7-4EA7-AD6A-44D3C3FD6070Q36397454-DD1E9D61-BBE6-40A2-BF3B-9F37D543F84FQ36400586-1766FE2F-D7A0-43B0-9500-046A90AFD7E9Q36837631-79922A8D-0977-4991-B483-DDBBCBAA79FEQ37376709-F85F0E41-9E3E-4474-A07C-C53D589EBA77Q38042327-8780159F-0089-4962-B30E-0FFBB7B6EC2EQ38630384-991D4EFD-4629-42DD-B50F-975DA8A90678Q39143432-6E33195B-346F-4377-B6F7-6C9BF56A7065Q39507440-C5A0DCA4-A1CC-44B0-B193-EBF626BE52ABQ39577917-683D77B0-20D3-4425-83EA-9AF6DF79A967Q39594848-9EA64DE4-EBBC-4DF2-BB1F-2FBA3E444B8FQ39604619-03C7D0FE-32BE-4555-84F6-BD140E96E5BDQ39868718-BE858B07-0BBF-4350-B132-3C6C8B620691Q39871557-4E2CA87A-BD2E-4F4C-AD81-DDC15DE9C104Q39996413-9B46AB7B-10DB-4641-AB6C-D2D4ACA65FA5Q40358106-72AE8609-BC6A-4C0B-AF51-BBD8E59B670AQ40962318-37E8FA9E-8BAD-4FB9-A21E-72C01AD1F4F8Q42971842-4E7A4921-36D4-46DC-B93D-BD02C39154C5Q45735893-6B8EC85E-D3F4-42B5-A161-DC9F765CA7E8Q45858552-ECB866A3-ED05-49FB-911B-67C50BA1B78A
P2860
Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Participation of endogenous tu ...... to cytomegalovirus infection.
@en
Participation of endogenous tu ...... to cytomegalovirus infection.
@nl
type
label
Participation of endogenous tu ...... to cytomegalovirus infection.
@en
Participation of endogenous tu ...... to cytomegalovirus infection.
@nl
prefLabel
Participation of endogenous tu ...... to cytomegalovirus infection.
@en
Participation of endogenous tu ...... to cytomegalovirus infection.
@nl
P2093
P50
P1476
Participation of endogenous tu ...... e to cytomegalovirus infection
@en
P2093
Crnković I
Koszinowski UH
P304
P356
10.1099/0022-1317-74-10-2215
P407
P478
74 ( Pt 10)
P577
1993-10-01T00:00:00Z